Pathways Hospital Units - Psychiatric Unit Medicare: Not Enrolled in Medicare Practice Location: 708 S 1st St, Muleshoe, TX 79347 Phone: 806-272-5421 Fax: 806-272-5623 |
News Archive
New research from the University of Pittsburgh School of Medicine and the UPMC Hillman Cancer Center sheds light on how tumors use the body's regulators of immunity for their own benefit.
A study has found that men are significantly more likely to suffer severe effects of COVID-19 and die.
Officials in Maryland's Prince George's County say they "will spare no time or expense" investigating the circumstances surrounding the death of a veteran public health worker who died of COVID-19 after relatives and co-workers believe she contracted the coronavirus on the job.
XenoPort, Inc. announced today that it will present data on a new preclinical product candidate, XP23829, at the upcoming 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Gothenburg, Sweden, October 13 - 16, 2010.
BioSante Pharmaceuticals, Inc. today announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd.. The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
› Verified 2 days ago